Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISKE KLINIK KLAUS DOKTOR.HERNING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.6% 0.8% 3.4% 2.0% 1.4% 1.5% 8.6% 8.5%   Credit score (0-100)   76 94 54 67 78 74 29 29   Credit rating   A AA BBB A A A BB BB   Credit limit (kDKK)   12.6 656.9 0.0 0.6 66.5 20.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   339 1,135 -75.9 315 601 569 0.0 0.0   EBITDA   298 1,030 -583 178 596 454 0.0 0.0   EBIT   172 885 -687 102 484 300 0.0 0.0   Pre-tax profit (PTP)   83.2 836.3 -740.0 52.9 401.4 132.4 0.0 0.0   Net earnings   41.4 667.0 -593.0 34.2 304.6 70.8 0.0 0.0   Pre-tax profit without non-rec. items   83.2 836 -740 52.9 401 132 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   409 547 489 413 690 594 0.0 0.0   Shareholders equity total   6,214 6,844 6,211 6,199 6,446 6,458 6,272 6,272   Interest-bearing liabilities   749 756 1,644 966 3,450 3,185 0.0 0.0   Balance sheet total (assets)   7,155 7,964 8,158 7,354 10,304 10,162 6,272 6,272   Net Debt   694 701 1,589 911 3,395 3,055 -6,272 -6,272     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   339 1,135 -75.9 315 601 569 0.0 0.0   Gross profit growth   -43.6% 234.6% 0.0% 0.0% 90.8% -5.3% -100.0% 0.0%   Employees   1 1 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,155 7,964 8,158 7,354 10,304 10,162 6,272 6,272   Balance sheet change%   -24.2% 11.3% 2.4% -9.9% 40.1% -1.4% -38.3% 0.0%   Added value   297.9 1,030.3 -582.5 178.1 559.9 454.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -198 -8 -162 -152 164 -249 -594 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   50.8% 78.0% 904.6% 32.4% 80.5% 52.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.1% 11.7% -8.4% 1.7% 5.7% 3.1% 0.0% 0.0%   ROI %   2.2% 12.2% -8.8% 1.7% 5.9% 3.3% 0.0% 0.0%   ROE %   0.7% 10.2% -9.1% 0.6% 4.8% 1.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   86.8% 85.9% 76.1% 84.3% 62.6% 63.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   232.8% 68.0% -272.8% 511.7% 569.2% 672.3% 0.0% 0.0%   Gearing %   12.0% 11.0% 26.5% 15.6% 53.5% 49.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 6.5% 5.0% 5.8% 4.4% 5.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.9 0.7 1.2 0.3 0.3 0.0 0.0   Current Ratio   0.5 0.9 0.7 1.2 0.3 0.3 0.0 0.0   Cash and cash equivalent   54.9 54.9 54.9 54.9 54.9 129.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -479.6 -149.2 -685.5 166.9 -2,765.4 -2,823.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   298 1,030 -583 178 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   298 1,030 -583 178 0 0 0 0   EBIT / employee   172 885 -687 102 0 0 0 0   Net earnings / employee   41 667 -593 34 0 0 0 0